Accelerate to the Clinic Novel, New Generation Cell Therapies that are Safer, More Effective and Have Meaningful Impact in Diseases Beyond Oncology
As the CAR-T field continues to explode with new companies, investment, and clinical collaborations, it's more important than ever to stay ahead of the curve. Stakeholders across oncology are now turning to next generation developments and innovations to create the therapies of tomorrow.
That’s why CAR-TCR Europe has evolved into the Next Generation CAR-TCR Summit: your definitive platform focused on the 2.0, next generation innovations in cell therapies.
Join innovators from large pharma, biotech, academia and regulatory boards to hear insights into:
Novel In-Vivo Delivery | Innovations in Gene, Base & Prime Editing | Novel Discovery Platforms | Overcoming the Hostile Tumour Microenvironment | Improving Persistence and Durability for Greater Clinical Outcomes | And More!
Whether you are developing novel constructs, new clinical trial strategies or innovative manufacturing approaches for large scale production, this multi-tracked meeting can support your whole team and provide the tools needed to advance your own pipeline towards clinical and commercial success.